Authors
Loading...
Review reveals therapeutic benefits and manufacturing hurdles of next-generation probiotics in humans, highlighting delivery systems and safety frameworks essential for commercialization.
Jan et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: